Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$10.1B
111M shares
52-week range
$61.95 – $92.18
92% from low
Sector
WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Exchange
NASDAQ
CS
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
www.henryschein.comNo one on the platform currently holds HSIC.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 39,012 | $2.6M |
| Bridgewater Associatesas of 2026-03-31 | 32,098 | $2.4M |
| Execution date | Ratio |
|---|---|
| 2019-02-08 | 1275-for-1000 |
| 2017-09-15 | 2-for-1 |
| 2005-03-01 | 2-for-1 |
No one on the platform has traded HSIC yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$HSIC reported 1.27 EPS and 3,458 revenue for Q2. http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_content=HSIC&utm_
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-8-4-henry-schein-inc-stock/ $HSIC Henry Schein Earnings Transcript
View on StockTwits ↗$HSIC Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.83 up 16.90% YoY • Reported revenue of $3.46B up 6.73% YoY • Henry Schein raised its FY2026 guidance, now projecting non-GAAP diluted EPS of $5.29 to $5.39, total sales growth of 4.5% to 5.5%, and Adjusted EBITDA growth in the mid to high-single-digits.
View on StockTwits ↗$HSIC BMO Capital Markets has altered their rating of "Market Perform" and target of "$85" see consensus outlook
View on StockTwits ↗$HSIC Haven't looked at this one in a bit, now over a major resistance and setting up for a trade. ATH look
View on StockTwits ↗$HSIC Share Price: $76.05 Contract Selected: Nov 20, 2026 $75 Calls Buy Zone: $5.47 – $6.76 Target Zone: $9.52 – $11.64 Potential Upside: 64% ROI Time to Expiration: 170 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗https://marketbeat.com/a/8682794/ $HSIC Henry Schein Sees Steady Dental Demand, $125M Profit Lift by 2026
View on StockTwits ↗$HSIC Henry Schein has operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners. Long term trend is not attractive; however, you could trade between the ~$65 - $85 range if the cycle holds.
View on StockTwits ↗https://marketbeat.com/a/8660047/ $HSIC Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness
View on StockTwits ↗$HSIC Insider purchase: https://www.sec.gov/Archives/edgar/data/1000228/000119312526219491/xslF345X06/ownership.xml
View on StockTwits ↗$HSIC Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.93 up 4.49% YoY • Reported revenue of $3.37B up 6.31% YoY • Henry Schein reaffirmed 2026 guidance for non-GAAP diluted EPS of $5.23 to $5.37 and total sales growth of approximately 3% to 5% over 2025, with Adjusted EBITDA expected to grow mid-single digits.
View on StockTwits ↗$HSIC Opportunity Citigroup initiates coverage with buy rating; PT $100
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.